Interní Med. 2016; 18(2): 100-102 | DOI: 10.36290/int.2016.024

Campylobacter myocarditis with septic shock and STEMI equivalent in a young patient

MUDr.Jakub Rychlík1, MUDr.Martin Zeman2, MUDr.Jiří Hlas1, MUDr.Petr Šimek1, MUDr.Milan Sepši, Ph.D.3, MUDr.Zdeněk Klimsa1
1 Kardiologické oddělení Nemocnice Jihlava
2 Ústav soudního lékařství FNUSA Brno
3 Interní kardiologická klinika FN Brno

In this paper we present a case report of a young patient that was hospitalized in Jihlava hospital for gastroenteritis with fulminant

progress resulting in septic shock. Stool cultivation was positive for Campylobacter jejuni. Bacterial infection caused perimyocarditis

with transient ST elevation in unipolar leads V1-V3. Patient recovered completely after ampicilin and ciprofloxacin therapy

including 6 months of follow up. To our best knowledge this is the first documented case of periomyocarditis associated with C.

jejuni infection in the Czech Republic.

Keywords: perimyocarditis, Campylobacter jejuni, shock, ST segment elevation myocardial infarction (STEMI)

Published: May 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rychlík J, Zeman M, Hlas J, Šimek P, Sepši M, Klimsa Z. Campylobacter myocarditis with septic shock and STEMI equivalent in a young patient. Interní Med. 2016;18(2):100-102. doi: 10.36290/int.2016.024.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Anderson BR, Silver ES, et al. Usefulness of arrhythmias as predictors of death and resource utilization in children with myocarditis. Am J Cardiol 2014; 114: 1400-1405. Go to original source...
    2. Kuchynka P, Palecek T, et al. New therapeutic aspects of inflammatory cardiomyopathy. Curr Pharm Des 2014; 21: 459-465. Go to original source...
    3. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation 2006; 113: 876-890. Go to original source...
    4. Krause PJ, Bockenstedt LK. Cardiology patient pages: Lyme disease and the heart. Circulation 2013; 127: e451-e454. Go to original source... Go to PubMed...
    5. Williams P, Lainchbury J. Enteritis-associated myokarditis. Heart Lung Circul 2004; 13: 106-109. Go to original source...
    6. Alzand BSN, Ilhan M, et al. Campylobacter jejuni: Enterocolitis and myopericarditis. Int J Cardiol 2010; 144: e14-e16. Go to original source...
    7. Chaubey VK, Chhabra L, Perm J. Spodick's sign: a helpful electrocardiographic clue to the diagnosis of acute pericarditis. Perm J 2014; 18: e122. Go to original source...
    8. Burlo P, Comino A, et al. Adult myocarditis in a general hospital: observations on 605 autopsies. Pathologica 1995; 87: 646-649. Go to PubMed...
    9. Gibreel A, Taylor DE. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 2006; 58: 243-255. Go to original source... Go to PubMed...
    10. Gonzalez-Abad MJ, Alonso-Sanz M. Incidence and susceptibility of Campylobacter jejuni in pediatric patients: involvement in bacteremia. Rev Esp Quimioter 2013; 26: 92-96. Go to PubMed...
    11. Souček M, Husa P. Vnitřní lékařství: díl 2., Kampylobakterióza, 1. vyd., Praha: Grada, 2011; strana 1174, ISBN 978-80-247-2110-1.
    12. Font C, Cruceta A, et al. A study of 30 patients with bacteremia due to Campylobacter spp. Med Clin 1997; 108: 336-340.
    13. Rafi A, Matz J. An unusual case of Campylobacter jejuni pericarditis in a patient with X-linked agammaglobulinemia. Ann Allergy Asthma Immunol 2002; 89: 362-367. Go to original source... Go to PubMed...
    14. Wassenaar TM. Toxin production by Campylobacter spp. Clin Microbiol Rev 1997; 10: 466-476. Go to original source... Go to PubMed...
    15. Cooper L, Baughman K, et al. ESC Clinical Practice Guidelines. The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease. Eur Heart J 2007; 28: 3076-3093. Go to original source...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.